CCRM

Commercializing Living Therapies with CCRM

Hear from academic and industry experts sharing insider insights, information and trend forecasts for the cell and gene therapy industry. “Commercializing Living Therapies with CCRM” is brought to you by CCRM, a leader in developing, manufacturing and commercializing regenerative medicine-based technologies, and cell and gene therapies. Questions / comments? email: podcast@ccrm.ca.

Husk at besøge podcastens hjemmeside og støtte skaberen: www.ccrm.ca

Forfatter

CCRM

Kategori

Science

Podcastens hjemmeside

www.ccrm.ca

Seneste episode

15. okt. 2026

Hvor kan du lytte?

Podcasts i appen Replaio Radio Kommer snart

Podcasts kommer snart til appen. Installer nu, og vær den første til at se en helt ny tilgang til podcasts

Hent den på Google Play Installer gratis Android 10 mio.+ downloads · 4,7+ i bedømmelse iOS snart

Episoder

Moving from A to B 14.02.2022

Manufacturing and supply chain issues in cell and gene therapies.    Featuring:  Dr. Anthony Davies, Founder and CEO, Dark Horse Consulting  Rob Jones, Vice President, Global Bioservices, Cryoport Systems   It’s no secret that supply chain and manufacturing are crucial to the cell and gene therapy industry, but now the whole world seems to be paying attention. This sudden interest has made Anthony...

Chaperoning innovation through the valley of death 14.01.2022

The business of regenerative medicine and investment.   Featuring:  Dr. Cynthia Lavoie, President and Chief Investment Officer, CCRM Enterprises  Geoff MacKay, President and CEO, AVROBIO  Dr. Lavoie and Mr. MacKay share what brought them to regenerative medicine in the first place, why investors are bullish about the field, and which trends they have an eye on as they are looking to the future. Jo...

The importance of educating the public about cell and gene therapies 14.12.2021

How can the regenerative medicine community create broader societal awareness?  Featuring:  Dr. Janet Rossant, President and Scientific Director, Gairdner Foundation Dr. Phil Vanek, Chief Technology Officer, Gamma Biosciences Drs. Rossant and Vanek discuss public awareness of cell and gene therapies, the importance of improving it, and how confusing and misleading claims made about unapproved stem...

Lyt til podcasten Commercializing Living Therapies with CCRM i Replaio

Radio og podcasts i én app - gratis og uden tilmelding. Installer i dag, og gå ikke glip af lanceringen

Hent den på Google Play

Replaio er ikke podcastudgiver; programmernes navne, coverbilleder og lyd tilhører deres ophavsmænd og distribueres via offentlige RSS-feeds.